To promote academic exchange in the fields of endocrinology and diabetes, keep track of the latest research progress both domestically and internationally, and enhance the clinical diagnosis and treatment capabilities as well as research competencies for related diseases, the "Endocrine and Diabetes Symposium," organized by the Chengdu High-Tech Zone Medical Association, is scheduled to take place in Luzhou on September 12, 2025.

This conference aims to address the urgent need for chronic disease prevention and control in China, with a focus on the rapid advancements and transformative developments in endocrinology and metabolism, particularly in the diagnosis and treatment of diabetes. As lifestyle changes and population aging accelerate, diabetes and its complications have become significant public health challenges that severely impact national health and quality of life. Meanwhile, the emergence of new hypoglycemic drugs, the integration of precision medicine concepts, and innovations in digital management tools are driving rapid evolution in clinical practice. The conference is committed to establishing a high-level platform for academic exchange and collaboration. By deeply exploring disease mechanisms, sharing cutting-edge research findings, and analyzing typical and complex cases, it seeks to foster the integration and convergence of multidisciplinary perspectives, thereby advancing the optimization of diagnostic and treatment standards, facilitating the implementation of personalized treatment strategies, and improving the capacity for grassroots prevention and management.